Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

January 31, 2025

Conditions
DeliriumCognitive DeclineFrailty
Interventions
DRUG

Dexmedetomidine

Continous intravenous infusion

DRUG

Clonidine

Continous intravenous infusion

DRUG

Natriumchlorid

Continous intravenous infusion NaCl

Trial Locations (5)

Unknown

RECRUITING

Haukeland University Hospital, Bergen

RECRUITING

Oslo University Hospital Rikshospitalet, Oslo

RECRUITING

Oslo University Hospital Ullevål, Oslo

RECRUITING

University Hospital of North Norway, Tromsø

RECRUITING

St Olav University Hospital, Trondheim

All Listed Sponsors
collaborator

Haukeland University Hospital

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

collaborator

St. Olavs Hospital

OTHER

lead

Oslo University Hospital

OTHER

NCT05029050 - Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery | Biotech Hunter | Biotech Hunter